The global endometriosis treatment market is on a robust growth trajectory. Estimated to be worth USD 1.55 billion in 2023, the market is expected to grow at a compound annual growth rate (CAGR) of 7.7% through the forecast period, reaching an anticipated value of USD 3.02 billion by 2032. This growth is fueled by increased research and development (R&D) activities, rising awareness about endometriosis, and the growing demand for effective therapeutic options. In this article, we will explore th
